Lysosomal Storage Diseases Therapeutics Market
1 Study Coverage
1.1 Lysosomal Storage Diseases Therapeutics Revenue in Lysosomal Storage Diseases Therapeutics Business (2017-2022) & (US$ Million) Introduction
1.2 Global Lysosomal Storage Diseases Therapeutics Outlook 2017 VS 2022 VS 2028
1.2.1 Global Lysosomal Storage Diseases Therapeutics Market Size for the Year 2017-2028
1.2.2 Global Lysosomal Storage Diseases Therapeutics Market Size for the Year 2017-2028
1.3 Lysosomal Storage Diseases Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Lysosomal Storage Diseases Therapeutics in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Lysosomal Storage Diseases Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Lysosomal Storage Diseases Therapeutics Market Dynamics
1.4.1 Lysosomal Storage Diseases Therapeutics Industry Trends
1.4.2 Lysosomal Storage Diseases Therapeutics Market Drivers
1.4.3 Lysosomal Storage Diseases Therapeutics Market Challenges
1.4.4 Lysosomal Storage Diseases Therapeutics Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Lysosomal Storage Diseases Therapeutics by Type
2.1 Lysosomal Storage Diseases Therapeutics Market Segment by Type
2.1.1 Enzyme Replacement Therapy
2.1.2 Stem Cell Therapy
2.1.3 Substrate Reduction Therapy
2.1.4 Others
2.2 Global Lysosomal Storage Diseases Therapeutics Market Size by Type (2017, 2022 & 2028)
2.3 Global Lysosomal Storage Diseases Therapeutics Market Size by Type (2017-2028)
2.4 United States Lysosomal Storage Diseases Therapeutics Market Size by Type (2017, 2022 & 2028)
2.5 United States Lysosomal Storage Diseases Therapeutics Market Size by Type (2017-2028)
3 Lysosomal Storage Diseases Therapeutics by Application
3.1 Lysosomal Storage Diseases Therapeutics Market Segment by Application
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Lysosomal Storage Diseases Therapeutics Market Size by Application (2017, 2022 & 2028)
3.3 Global Lysosomal Storage Diseases Therapeutics Market Size by Application (2017-2028)
3.4 United States Lysosomal Storage Diseases Therapeutics Market Size by Application (2017, 2022 & 2028)
3.5 United States Lysosomal Storage Diseases Therapeutics Market Size by Application (2017-2028)
4 Global Lysosomal Storage Diseases Therapeutics Competitor Landscape by Company
4.1 Global Lysosomal Storage Diseases Therapeutics Market Size by Company
4.1.1 Top Global Lysosomal Storage Diseases Therapeutics Companies Ranked by Revenue (2021)
4.1.2 Global Lysosomal Storage Diseases Therapeutics Revenue by Player (2017-2022)
4.2 Global Lysosomal Storage Diseases Therapeutics Concentration Ratio (CR)
4.2.1 Lysosomal Storage Diseases Therapeutics Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Lysosomal Storage Diseases Therapeutics in 2021
4.2.3 Global Lysosomal Storage Diseases Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Lysosomal Storage Diseases Therapeutics Headquarters, Revenue in Lysosomal Storage Diseases Therapeutics Business (2017-2022) & (US$ Million) Type
4.3.1 Global Lysosomal Storage Diseases Therapeutics Headquarters and Area Served
4.3.2 Global Lysosomal Storage Diseases Therapeutics Companies Revenue in Lysosomal Storage Diseases Therapeutics Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Lysosomal Storage Diseases Therapeutics Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Lysosomal Storage Diseases Therapeutics Market Size by Company
4.5.1 Top Lysosomal Storage Diseases Therapeutics Players in United States, Ranked by Revenue (2021)
4.5.2 United States Lysosomal Storage Diseases Therapeutics Revenue by Players (2020, 2021 & 2022)
5 Global Lysosomal Storage Diseases Therapeutics Market Size by Region
5.1 Global Lysosomal Storage Diseases Therapeutics Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Lysosomal Storage Diseases Therapeutics Market Size by Region (2017-2028)
5.2.1 Global Lysosomal Storage Diseases Therapeutics Market Size by Region: 2017-2022
5.2.2 Global Lysosomal Storage Diseases Therapeutics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Lysosomal Storage Diseases Therapeutics Market Size YoY Growth 2017-2028
6.1.2 North America Lysosomal Storage Diseases Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Lysosomal Storage Diseases Therapeutics Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Lysosomal Storage Diseases Therapeutics Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Lysosomal Storage Diseases Therapeutics Market Size YoY Growth 2017-2028
6.3.2 Europe Lysosomal Storage Diseases Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Lysosomal Storage Diseases Therapeutics Market Size YoY Growth 2017-2028
6.4.2 Latin America Lysosomal Storage Diseases Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Lysosomal Storage Diseases Therapeutics Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Lysosomal Storage Diseases Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Takeda
7.1.1 Takeda Company Details
7.1.2 Takeda Business Overview
7.1.3 Takeda Lysosomal Storage Diseases Therapeutics Introduction
7.1.4 Takeda Revenue in Lysosomal Storage Diseases Therapeutics Business (2017-2022)
7.1.5 Takeda Recent Development
7.2 Pfizer
7.2.1 Pfizer Company Details
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Lysosomal Storage Diseases Therapeutics Introduction
7.2.4 Pfizer Revenue in Lysosomal Storage Diseases Therapeutics Business (2017-2022)
7.2.5 Pfizer Recent Development
7.3 Sanofi
7.3.1 Sanofi Company Details
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Lysosomal Storage Diseases Therapeutics Introduction
7.3.4 Sanofi Revenue in Lysosomal Storage Diseases Therapeutics Business (2017-2022)
7.3.5 Sanofi Recent Development
7.4 BioMarin Pharmaceutical
7.4.1 BioMarin Pharmaceutical Company Details
7.4.2 BioMarin Pharmaceutical Business Overview
7.4.3 BioMarin Pharmaceutical Lysosomal Storage Diseases Therapeutics Introduction
7.4.4 BioMarin Pharmaceutical Revenue in Lysosomal Storage Diseases Therapeutics Business (2017-2022)
7.4.5 BioMarin Pharmaceutical Recent Development
7.5 Actelion Ltd
7.5.1 Actelion Ltd Company Details
7.5.2 Actelion Ltd Business Overview
7.5.3 Actelion Ltd Lysosomal Storage Diseases Therapeutics Introduction
7.5.4 Actelion Ltd Revenue in Lysosomal Storage Diseases Therapeutics Business (2017-2022)
7.5.5 Actelion Ltd Recent Development
7.6 Raptor Pharmaceutical
7.6.1 Raptor Pharmaceutical Company Details
7.6.2 Raptor Pharmaceutical Business Overview
7.6.3 Raptor Pharmaceutical Lysosomal Storage Diseases Therapeutics Introduction
7.6.4 Raptor Pharmaceutical Revenue in Lysosomal Storage Diseases Therapeutics Business (2017-2022)
7.6.5 Raptor Pharmaceutical Recent Development
7.7 Protalix BiOthersapeutics
7.7.1 Protalix BiOthersapeutics Company Details
7.7.2 Protalix BiOthersapeutics Business Overview
7.7.3 Protalix BiOthersapeutics Lysosomal Storage Diseases Therapeutics Introduction
7.7.4 Protalix BiOthersapeutics Revenue in Lysosomal Storage Diseases Therapeutics Business (2017-2022)
7.7.5 Protalix BiOthersapeutics Recent Development
7.8 Amicus Therapeutics
7.8.1 Amicus Therapeutics Company Details
7.8.2 Amicus Therapeutics Business Overview
7.8.3 Amicus Therapeutics Lysosomal Storage Diseases Therapeutics Introduction
7.8.4 Amicus Therapeutics Revenue in Lysosomal Storage Diseases Therapeutics Business (2017-2022)
7.8.5 Amicus Therapeutics Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Lysosomal Storage Diseases Therapeutics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Lysosomal Storage Diseases Therapeutics Market Trends
Table 3. Lysosomal Storage Diseases Therapeutics Market Drivers
Table 4. Lysosomal Storage Diseases Therapeutics Market Challenges
Table 5. Lysosomal Storage Diseases Therapeutics Market Restraints
Table 6. Global Lysosomal Storage Diseases Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Lysosomal Storage Diseases Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Lysosomal Storage Diseases Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Lysosomal Storage Diseases Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Lysosomal Storage Diseases Therapeutics Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Lysosomal Storage Diseases Therapeutics Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Lysosomal Storage Diseases Therapeutics Revenue Share by Player, 2017-2022
Table 13. Global Lysosomal Storage Diseases Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Lysosomal Storage Diseases Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lysosomal Storage Diseases Therapeutics as of 2021)
Table 15. Top Players of Lysosomal Storage Diseases Therapeutics in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Lysosomal Storage Diseases Therapeutics Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Lysosomal Storage Diseases Therapeutics Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Lysosomal Storage Diseases Therapeutics Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Lysosomal Storage Diseases Therapeutics Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Lysosomal Storage Diseases Therapeutics Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Lysosomal Storage Diseases Therapeutics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Lysosomal Storage Diseases Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Lysosomal Storage Diseases Therapeutics Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Lysosomal Storage Diseases Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Lysosomal Storage Diseases Therapeutics Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Lysosomal Storage Diseases Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Lysosomal Storage Diseases Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Lysosomal Storage Diseases Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Takeda Company Details
Table 31. Takeda Business Overview
Table 32. Takeda Lysosomal Storage Diseases Therapeutics Product
Table 33. Takeda Revenue in Lysosomal Storage Diseases Therapeutics Business (2017-2022) & (US$ Million)
Table 34. Takeda Recent Development
Table 35. Pfizer Company Details
Table 36. Pfizer Business Overview
Table 37. Pfizer Lysosomal Storage Diseases Therapeutics Product
Table 38. Pfizer Revenue in Lysosomal Storage Diseases Therapeutics Business (2017-2022) & (US$ Million)
Table 39. Pfizer Recent Development
Table 40. Sanofi Company Details
Table 41. Sanofi Business Overview
Table 42. Sanofi Lysosomal Storage Diseases Therapeutics Product
Table 43. Sanofi Revenue in Lysosomal Storage Diseases Therapeutics Business (2017-2022) & (US$ Million)
Table 44. Sanofi Recent Development
Table 45. BioMarin Pharmaceutical Company Details
Table 46. BioMarin Pharmaceutical Business Overview
Table 47. BioMarin Pharmaceutical Lysosomal Storage Diseases Therapeutics Product
Table 48. BioMarin Pharmaceutical Revenue in Lysosomal Storage Diseases Therapeutics Business (2017-2022) & (US$ Million)
Table 49. BioMarin Pharmaceutical Recent Development
Table 50. Actelion Ltd Company Details
Table 51. Actelion Ltd Business Overview
Table 52. Actelion Ltd Lysosomal Storage Diseases Therapeutics Product
Table 53. Actelion Ltd Revenue in Lysosomal Storage Diseases Therapeutics Business (2017-2022) & (US$ Million)
Table 54. Actelion Ltd Recent Development
Table 55. Raptor Pharmaceutical Company Details
Table 56. Raptor Pharmaceutical Business Overview
Table 57. Raptor Pharmaceutical Lysosomal Storage Diseases Therapeutics Product
Table 58. Raptor Pharmaceutical Revenue in Lysosomal Storage Diseases Therapeutics Business (2017-2022) & (US$ Million)
Table 59. Raptor Pharmaceutical Recent Development
Table 60. Protalix BiOthersapeutics Company Details
Table 61. Protalix BiOthersapeutics Business Overview
Table 62. Protalix BiOthersapeutics Lysosomal Storage Diseases Therapeutics Product
Table 63. Protalix BiOthersapeutics Revenue in Lysosomal Storage Diseases Therapeutics Business (2017-2022) & (US$ Million)
Table 64. Protalix BiOthersapeutics Recent Development
Table 65. Amicus Therapeutics Company Details
Table 66. Amicus Therapeutics Business Overview
Table 67. Amicus Therapeutics Lysosomal Storage Diseases Therapeutics Product
Table 68. Amicus Therapeutics Revenue in Lysosomal Storage Diseases Therapeutics Business (2017-2022) & (US$ Million)
Table 69. Amicus Therapeutics Recent Development
Table 70. Research Programs/Design for This Report
Table 71. Key Data Information from Secondary Sources
Table 72. Key Data Information from Primary Sources
List of Figures
Figure 1. Lysosomal Storage Diseases Therapeutics Product Picture
Figure 2. Global Lysosomal Storage Diseases Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Lysosomal Storage Diseases Therapeutics Market Size 2017-2028 (US$ Million)
Figure 4. United States Lysosomal Storage Diseases Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Lysosomal Storage Diseases Therapeutics Market Size 2017-2028 (US$ Million)
Figure 6. United States Lysosomal Storage Diseases Therapeutics Market Share in Global 2017-2028
Figure 7. Lysosomal Storage Diseases Therapeutics Report Years Considered
Figure 8. Product Picture of Enzyme Replacement Therapy
Figure 9. Product Picture of Stem Cell Therapy
Figure 10. Product Picture of Substrate Reduction Therapy
Figure 11. Product Picture of Others
Figure 12. Global Lysosomal Storage Diseases Therapeutics Market Share by Type in 2022 & 2028
Figure 13. Global Lysosomal Storage Diseases Therapeutics Market Size by Type (2017-2028) & (US$ Million)
Figure 14. Global Lysosomal Storage Diseases Therapeutics Market Share by Type (2017-2028)
Figure 15. United States Lysosomal Storage Diseases Therapeutics Market Share by Type in 2022 & 2028
Figure 16. United States Lysosomal Storage Diseases Therapeutics Market Size by Type (2017-2028) & (US$ Million)
Figure 17. United States Lysosomal Storage Diseases Therapeutics Market Share by Type (2017-2028)
Figure 18. Product Picture of Hospitals
Figure 19. Product Picture of Clinics
Figure 20. Product Picture of Others
Figure 21. Global Lysosomal Storage Diseases Therapeutics Market Share by Application in 2022 & 2028
Figure 22. Global Lysosomal Storage Diseases Therapeutics Market Size by Application (2017-2028) & (US$ Million)
Figure 23. Global Lysosomal Storage Diseases Therapeutics Market Share by Application (2017-2028)
Figure 24. United States Lysosomal Storage Diseases Therapeutics Market Share by Application in 2022 & 2028
Figure 25. United States Lysosomal Storage Diseases Therapeutics Market Size by Application (2017-2028) & (US$ Million)
Figure 26. United States Lysosomal Storage Diseases Therapeutics Market Share by Application (2017-2028)
Figure 27. North America Lysosomal Storage Diseases Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 28. U.S. Lysosomal Storage Diseases Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 29. Canada Lysosomal Storage Diseases Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. Europe Lysosomal Storage Diseases Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 31. Germany Lysosomal Storage Diseases Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. France Lysosomal Storage Diseases Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. U.K. Lysosomal Storage Diseases Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Italy Lysosomal Storage Diseases Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Russia Lysosomal Storage Diseases Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Asia-Pacific Lysosomal Storage Diseases Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 37. China Lysosomal Storage Diseases Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. Japan Lysosomal Storage Diseases Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. South Korea Lysosomal Storage Diseases Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. India Lysosomal Storage Diseases Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Australia Lysosomal Storage Diseases Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Taiwan Lysosomal Storage Diseases Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Indonesia Lysosomal Storage Diseases Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Thailand Lysosomal Storage Diseases Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Malaysia Lysosomal Storage Diseases Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Philippines Lysosomal Storage Diseases Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Latin America Lysosomal Storage Diseases Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 48. Mexico Lysosomal Storage Diseases Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Brazil Lysosomal Storage Diseases Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Argentina Lysosomal Storage Diseases Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Middle East & Africa Lysosomal Storage Diseases Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 52. Turkey Lysosomal Storage Diseases Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Lysosomal Storage Diseases Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. U.A.E Lysosomal Storage Diseases Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 55. Takeda Revenue Growth Rate in Lysosomal Storage Diseases Therapeutics Business (2017-2022)
Figure 56. Pfizer Revenue Growth Rate in Lysosomal Storage Diseases Therapeutics Business (2017-2022)
Figure 57. Sanofi Revenue Growth Rate in Lysosomal Storage Diseases Therapeutics Business (2017-2022)
Figure 58. BioMarin Pharmaceutical Revenue Growth Rate in Lysosomal Storage Diseases Therapeutics Business (2017-2022)
Figure 59. Actelion Ltd Revenue Growth Rate in Lysosomal Storage Diseases Therapeutics Business (2017-2022)
Figure 60. Raptor Pharmaceutical Revenue Growth Rate in Lysosomal Storage Diseases Therapeutics Business (2017-2022)
Figure 61. Protalix BiOthersapeutics Revenue Growth Rate in Lysosomal Storage Diseases Therapeutics Business (2017-2022)
Figure 62. Amicus Therapeutics Revenue Growth Rate in Lysosomal Storage Diseases Therapeutics Business (2017-2022)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Industry Market Size
